Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Takeda phase 3 trial data shows orteronel plus prednisone improved progression free survival in men with chemotherapy
Takeda phase 3 trial data shows orteronel plus prednisone improved progression free survival in men with chemotherapy
Takeda phase 3 trial data shows orteronel plus prednisone improved progression free survival in men with chemotherapy
Submitted by
admin
on May 17, 2014 - 10:46am
Source:
Pharmabiz
News Tags:
Takeda
orteronel
prostate cancer
Headline:
Takeda phase 3 trial data shows orteronel plus prednisone improved progression free survival in men with chemotherapy
Do Not Allow Advertisers to Use My Personal information
